Revelation Partners

Thrilled to share that our portfolio company, Arcadia, is partnering with Nordic Capital! A huge congratulations to the Arcadia team on this exciting milestone!

Cancer care is evolving to become more connected, proactive, and patient-centered. Discover how integrated #oncology solutions are shaping the future, from prevention to end-of-life care. Read our latest blog post to learn what this means for stakeholders across the ecosystem: https://lnkd.in/gVV9-jrt

Excited to have our Venture Partner, Eric Shiozaki, speaking at the Truist MedTech Conference today, sharing insights on the current #MedTech and #Healthcare fundraising & #IPO landscape. Looking forward to a great discussion!

Revelation Partners is heading to NYC for the Carmo Companies Private Market #Secondaries Meeting East on July 16th! If you'll be attending, we’d love to connect—reach out at info@revelation-partners.com to set up a time to meet and learn more about what we do.

Huge congratulations to our portfolio company Omada Health on its successful #IPO! We’re proud to have been part of the journey and we look forward to what’s ahead as they continue to scale their impact in #healthcare: https://lnkd.in/g2xSapkT

Big thanks to all who attended last week’s Rising Healthcare Investors Wine Night! 🍷 Appreciate everyone who helped make it another successful #networking event – looking forward to the next one! 

The GP-led secondaries market has surged past $75B. In this short video, Fred Lee and Rob Rein break down why fund managers are turning to #secondaries and how everyone stands to gain.

Excited to share that our portfolio company LetsGetChecked has merged with Alto Pharmacy to launch Fuze Health, a technology-powered healthcare solutions company committed to transforming patient experiences and advancing personalized care: https://lnkd.in/erWnAy6M

Last week, our team headed to Carmel-by-the-Sea for an offsite—great strategy sessions, coastal hikes, and even some wine blending. Grateful for the time together outside the office.  

GLP-1s are more than a blockbuster drug trend—they’re the foundation of a fast-emerging #healthcare ecosystem. In our latest white paper, we break down where the market is heading, the business models gaining traction, and where #investors should be paying close attention.